Mike Cloutier is an accomplished business leader and consultant with over 40 years in the Life Sciences sector. 

Over the past 25 years, Mike was General Manager, President and CEO of five major pharmaceutical firms and one Not for Profit organization, the Canadian Diabetes Association (now Diabetes Canada). In 2017, Mike founded a Canadian based global consulting practice, Accelera Canada Ltd.  Accelera Canada provides unique and unparalleled “one top support” to US and European based biotech/pharmaceutical companies exploring commercial entry to Canada. In July of 2021, Accelera was acquired by Eversana Life Sciences Services.

Most recently, Mike co-founded Novescend (Accelera MedTech Canada Inc.) to provide consultation, in-licensing and distribution to US/EU based medical device innovators.

Prior to the role at Accelera Canada, Mike led organizations with interests in the Orphan and Rare disease market segments. As the General Manager and President of PTC Therapeutics Canada and InterMune Canada Inc., he ensured the delivery of tremendous support to patients and caregivers. These companies drove exceptional results in terms of optimal access for patients in need and financial success.

Mike has held positions in Latin America and Europe, serving as Senior Director, Operations, Latin America/Canada and as the Vice-President, Human Resources - Global Marketing for AstraZeneca Inc. 

Mike has been responsible for Life Cycle Management in a number of his senior leadership roles. In Canada, as both a senior marketing leader and as the CEO of a number of companies, he has been responsible to develop the strategy and to ensure excellence in the tactical implementation of plans for products in early, mid and late stages of their life cycle. He has engaged in many significant therapeutic classes including Oncology, Neuro-muscular, Cardiology, Gastroenterology, Infectious Disease and Inflammation. Mike has also provided leadership on a global scale in the US, Europe and Latin America. His leadership in Operations and Global Marketing provided Mike with the opportunity to set clear direction in determining the breadth and depth of product portfolios at Searle and AstraZeneca.

Mike is active on a strategic level sitting and leading a variety of Boards. He sits on the Boards of Arylide, ODAIA, Self Care Cataysts, OBIO and Alimentiv. He has previously Chaired the Board of Directors at Scientus, Merus Labs International and was a Board Director at Joule, a subsidiary of the Canadian Medical Association. As a result, Mike has an extensive network throughout Canada, the US and International circles.

Mike is a respected, dedicated philanthropist and has served on numerous Boards as a volunteer including the Canadian Stroke Network, Sheridan College Institute of Technology and Advanced Learning and the Canadian Orthopaedic Foundation. Mike is the past Fundraising Chair of the Hazel McCallion Academic Learning Centre at the University of Toronto Mississauga. 

Among his many accomplishments, Mike was inducted to the Sheridan College School of Business Marketing Hall of Fame and the Canadian Pharmaceutical Marketing Hall of Fame.

Speaking on: CIX TOP 20 EARLY SHOWCASE # 3